Dr. Pedram Hamrah, MD
Claim this profileTufts Medical Center
Studies Dry Eye Syndrome
Studies Neurotrophic Keratopathy
7 reported clinical trials
10 drugs studied
Area of expertise
1Dry Eye Syndrome
Stage II
Stage I
2Neurotrophic Keratopathy
Stage II
Stage I
Affiliated Hospitals
Clinical Trials Pedram Hamrah, MD is currently running
OK-101
for Neuropathic Corneal Pain
The primary objective of this study, in subjects with Neuropathic Corneal Pain, is to evaluate the efficacy and safety of OK-101 0.05% and 0.1% as compared to placebo instilled 4 times/day in subjects with neuropathic corneal pain, as assessed by visual analogue scale (VAS).
Recruiting0 awards Phase 22 criteria
RGN-259
for Neurotrophic Keratopathy
The objective of this study is to compare the safety and efficacy of RGN-259 to placebo for the treatment of Neurotrophic Keratopathy (NK)
Recruiting1 award Phase 3
More about Pedram Hamrah, MD
Clinical Trial Related6 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Pedram Hamrah, MD has experience with
- Quantitative Sensory Test
- OK-101
- Masked Placebo
- Valacyclovir
- Placebo
- RGN-259
Breakdown of trials Pedram Hamrah, MD has run
Dry Eye Syndrome
Neurotrophic Keratopathy
Corneal Diseases
Eye Disorder
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Pedram Hamrah, MD specialize in?
Pedram Hamrah, MD focuses on Dry Eye Syndrome and Neurotrophic Keratopathy. In particular, much of their work with Dry Eye Syndrome has involved Stage II patients, or patients who are Stage I.
Is Pedram Hamrah, MD currently recruiting for clinical trials?
Yes, Pedram Hamrah, MD is currently recruiting for 2 clinical trials in Boston Massachusetts. If you're interested in participating, you should apply.
Are there any treatments that Pedram Hamrah, MD has studied deeply?
Yes, Pedram Hamrah, MD has studied treatments such as Quantitative Sensory Test, OK-101, Masked Placebo.
What is the best way to schedule an appointment with Pedram Hamrah, MD?
Apply for one of the trials that Pedram Hamrah, MD is conducting.
What is the office address of Pedram Hamrah, MD?
The office of Pedram Hamrah, MD is located at: Tufts Medical Center, Boston, Massachusetts 02111 United States. This is the address for their practice at the Tufts Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.